Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.3390/cells11152403
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2022
- Creator
- DOI
-
10.18154/RWTH-CONV-249685
- URN
-
urn:nbn:de:101:1-2023040206331460008454
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:45 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Weiskirchen, Ralf
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2022
Other Objects (12)
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"